{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:53:49Z","timestamp":1790704429167,"version":"4.1.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002565","name":"Alzheimer's Drug Discovery Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008599","name":"Alzheimerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008599","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"H2020 European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010552","name":"Generalitat of Catalonia Department of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010552","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005062","name":"Fujirebio Europe","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["PID2020-119556RA-I00"],"award-info":[{"award-number":["PID2020-119556RA-I00"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["AEI\/10.13039\/501100011033"],"award-info":[{"award-number":["AEI\/10.13039\/501100011033"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CP23\/00039"],"award-info":[{"award-number":["CP23\/00039"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ebiom.2026.106331","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:54:59Z","timestamp":1781632499000},"page":"106331","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Detecting amyloid\u2013\u03b2 pathology in subjective cognitive decline using plasma and CSF biomarkers"],"prefix":"10.1016","volume":"129","author":[{"given":"Jos\u00e9","family":"Contador","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico Emanuele","family":"Pozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3454-800X","authenticated-orcid":false,"given":"Gonzalo","family":"S\u00e1nchez-Benavides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Fern\u00e1ndez-Arcos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Lantero-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7684-6318","authenticated-orcid":false,"given":"Laia","family":"Montoliu-Gaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Minguillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Fauria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armand","family":"Gonz\u00e1lez-Escalante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Ortiz-Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Blasco-Forni\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"de Diego-Osaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Jim\u00e9nez Moyano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Quijano-Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwendlyn","family":"Kollmorgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7981-2866","authenticated-orcid":false,"given":"Nathalie","family":"Le Bastard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Nadal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9466-5366","authenticated-orcid":false,"given":"Eugeen","family":"Vanmechelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Jeromin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Torres-Torronteras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Ashton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Domingo","family":"Gispert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Molinuevo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"del Campo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriol","family":"Grau-Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2993-569X","authenticated-orcid":false,"given":"Marc","family":"Su\u00e1rez-Calvet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida Fern\u00e1ndez","family":"Lebrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aitana Plaza","family":"Raimundo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Ca\u00f1as","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albina Polo","family":"Ballester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Brugulat","family":"Serrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Soteras","family":"Prat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabella Beteta","family":"Gorriti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carme","family":"Deulofeu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlota Medina","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"L\u00f3pez-Martos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Vallez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Ferrer i Mairal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda Campos","family":"Strazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Salvad\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene Navalpotro","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel Estragu\u00e9s","family":"Gazquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iva","family":"Knezevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Freixa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Huguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Gus\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Hern\u00e1ndez","family":"Penas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia Canals","family":"Gispert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Llu\u00eds","family":"Solsona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Vilanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Emilio","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Roman","family":"Cabiscol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireia S\u00e1nchez","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat Vil\u00e0","family":"Farr\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neus","family":"De la Cruz-S\u00e1nchez Badia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pau","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Marne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Cacciaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherezade","family":"Fuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier Mel\u00e9ndez","family":"Giner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ebiom.2026.106331_bib1","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jalz.2014.01.001","article-title":"A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer\u2019s disease","volume":"10","author":"Jessen","year":"2014","journal-title":"Alzheimers Dement"},{"issue":"17","key":"10.1016\/j.ebiom.2026.106331_bib2","doi-asserted-by":"crossref","first-page":"E1866","DOI":"10.1212\/WNL.0000000000201072","article-title":"Progression of subjective cognitive decline to MCI or dementia in relation to biomarkers for alzheimer disease: a meta-analysis","volume":"99","author":"Rostamzadeh","year":"2022","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106331_bib3","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.3233\/JAD-210218","article-title":"Biomarkers of alzheimer\u2019s disease and cerebrovascular lesions and clinical progression in patients with subjective cognitive decline: a systematic review","volume":"83","author":"Scarth","year":"2021","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106331_bib4","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/WNL.0000000000009724","article-title":"ATN classification and clinical progression in subjective cognitive decline: the SCIENCe project","volume":"95","author":"Ebenau","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.ebiom.2026.106331_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer\u2019s disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106331_bib6","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106331_bib7","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/alz.12748","article-title":"The AHEAD 3-45 study: design of a prevention trial for Alzheimer\u2019s disease","volume":"19","author":"Rafii","year":"2023","journal-title":"Alzheimers Dement"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106331_bib8","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.3233\/JAD-215178","article-title":"Association of subjective cognitive decline with cerebrospinal fluid biomarkers of Alzheimer\u2019s disease pathology in cognitively intact older adults: the CABLE study","volume":"85","author":"Wen","year":"2022","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106331_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-018-0463-y","article-title":"Prevalence of abnormal Alzheimer\u2019s disease biomarkers in patients with subjective cognitive decline: cross-sectional comparison of three European memory clinic samples","volume":"11","author":"Wolfsgruber","year":"2019","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.ebiom.2026.106331_bib10","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.neurobiolaging.2021.02.026","article-title":"Amyloid-\u03b2 positive individuals with subjective cognitive decline present increased CSF neurofilament light levels that relate to lower hippocampal volume","volume":"104","author":"S\u00e1nchez-Benavides","year":"2021","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.ebiom.2026.106331_bib11","first-page":"617","article-title":"Cerebrospinal fluid neurogranin\/\u03b2-site APP-cleaving enzyme 1 predicts cognitive decline in preclinical Alzheimer\u2019s disease","volume":"4","author":"Kirsebom","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106331_bib12","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12974-019-1399-2","article-title":"Glial activation and inflammation along the Alzheimer\u2019s disease continuum","volume":"16","author":"Nordengen","year":"2019","journal-title":"J Neuroinflamm"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106331_bib13","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/alz.12204","article-title":"An examination of a novel multipanel of CSF biomarkers in the Alzheimer\u2019s disease clinical and pathological continuum","volume":"17","author":"Van Hulle","year":"2021","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.ebiom.2026.106331_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1756286419888819","article-title":"Latest advances in cerebrospinal fluid and blood biomarkers of Alzheimer\u2019s disease","volume":"12","author":"Mil\u00e0-Alom\u00e0","year":"2019","journal-title":"Ther Adv Neurol Disord"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106331_bib15","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1111\/cns.14238","article-title":"Advances and applications of fluids biomarkers in diagnosis and therapeutic targets of Alzheimer\u2019s disease","volume":"29","author":"Xu","year":"2023","journal-title":"CNS Neurosci Ther"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106331_bib16","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13195-022-01143-z","article-title":"Clinical performance of an antibody-free assay for plasma A\u03b242\/A\u03b240 to detect early alterations of Alzheimer\u2019s disease in individuals with subjective cognitive decline","volume":"15","author":"Pascual-Lucas","year":"2023","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.ebiom.2026.106331_bib17","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.neurobiolaging.2020.01.007","article-title":"Plasma amyloid is associated with the rate of cognitive decline in cognitively normal elderly: the SCIENCe project","volume":"89","author":"Verberk","year":"2020","journal-title":"Neurobiol Aging"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106331_bib18","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/alz.13525","article-title":"A novel ultrasensitive assay for plasma p-tau217: performance in individuals with subjective cognitive decline and early Alzheimer\u2019s disease","volume":"20","author":"Gonzalez-Ortiz","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106331_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-020-00704-4","article-title":"Age and sex impact plasma NFL and t-Tau trajectories in individuals with subjective memory complaints: a 3-year follow-up study","volume":"12","author":"Baldacci","year":"2020","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106331_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-024-01478-9","article-title":"Comparison of plasma and neuroimaging biomarkers to predict cognitive decline in non-demented memory clinic patients","volume":"16","author":"Mendes","year":"2024","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.ebiom.2026.106331_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2023.120805","article-title":"Plasma p-tau181 as a promising non-invasive biomarker of Alzheimer\u2019s disease pathology in Subjective Cognitive Decline and Mild Cognitive Impairment","volume":"453","author":"Giacomucci","year":"2023","journal-title":"J Neurol Sci"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106331_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-08779-0","article-title":"Tau plasma levels in subjective cognitive decline: results from the DELCODE study","volume":"7","author":"M\u00fcller","year":"2017","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106331_bib23","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jalz.2016.09.012","article-title":"Implementation of Subjective Cognitive Decline criteria in research studies","volume":"13","author":"Molinuevo","year":"2017","journal-title":"Alzheimers Dement"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106331_bib24","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106331_bib25","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3233\/JAD-132027","article-title":"The subjective cognitive decline questionnaire (SCD-Q): a validation study","volume":"41","author":"Rami","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.ebiom.2026.106331_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105741","article-title":"A plasma biomarker panel for detecting early amyloid-\u03b2 accumulation and its changes in middle-aged cognitively unimpaired individuals at risk for Alzheimer\u2019s disease","volume":"116","author":"Gonz\u00e1lez-Escalante","year":"2025","journal-title":"EBioMedicine"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106331_bib27","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.14283\/jpad.2024.155","article-title":"Validation of an ultra-sensitive method for quantitation of Phospho-Tau 217 (pTau217) in human plasma, serum, and CSF using the ALZpath pTau217 assay on the quanterix HD-X platform","volume":"11","author":"Zhang","year":"2024","journal-title":"J Prev Alzheimers Dis"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106331_bib28","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00401-021-02275-6","article-title":"Plasma p-tau231: a new biomarker for incipient Alzheimer\u2019s disease pathology","volume":"141","author":"Ashton","year":"2021","journal-title":"Acta Neuropathol"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106331_bib29","first-page":"1797","article-title":"Plasma p-tau231 and p-tau217 as state markers of amyloid-\u03b2 pathology in preclinical Alzheimer\u2019s disease","volume":"28","author":"Mil\u00e0-Alom\u00e0","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2026.106331_bib30","series-title":"Evaluation of automatic class III designation for Lumipulse G 13-Amyloid Ratio (1-42\/1-40)","year":"2022"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106331_bib31","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.nrl.2022.05.005","article-title":"The CORCOBIA study: cut-off points of Alzheimer\u2019s disease CSF biomarkers in a clinical cohort","volume":"39","author":"Puig-Pijoan","year":"2024","journal-title":"Neurologia"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106331_bib32","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1515\/cclm-2022-0516","article-title":"Second-generation elecsys cerebrospinal fluid immunoassays aid diagnosis of early Alzheimer\u2019s disease","volume":"61","author":"Blennow","year":"2023","journal-title":"Clin Chem Lab Med"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106331_bib33","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcac174","article-title":"Establishment of reference values for plasma neurofilament light based on healthy individuals aged 5-90 years","volume":"4","author":"Simren","year":"2022","journal-title":"Brain Commun"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106331_bib34","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"10.1016\/j.ebiom.2026.106331_bib35","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1001\/jama.2024.13855","article-title":"Blood biomarkers to detect alzheimer disease in primary care and secondary care","volume":"20502","author":"Palmqvist","year":"2024","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106331_bib36","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41582-024-00977-5","article-title":"Acceptable performance of blood biomarker tests of amyloid pathology \u2014 recommendations from the Global CEO Initiative on Alzheimer\u2019s Disease","volume":"20","author":"Schindler","year":"2024","journal-title":"Nat Rev Neurol"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106331_bib37","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/s43587-023-00471-5","article-title":"A two-step workflow based on plasma p-tau217 to screen for amyloid \u03b2 positivity with further confirmatory testing only in uncertain cases","volume":"3","author":"Brum","year":"2023","journal-title":"Nat Aging"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106331_bib38","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13195-021-00942-0","article-title":"The accuracy and robustness of plasma biomarker models for amyloid PET positivity","volume":"14","author":"Benedet","year":"2022","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106331_bib39","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Series B Stat Methodol"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106331_bib40","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/alz.12694","article-title":"Global estimates on the number of persons across the Alzheimer\u2019s disease continuum","volume":"19","author":"Gustavsson","year":"2023","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106331_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-018-0390-y","article-title":"Subjective cognitive impairment cohort (SCIENCe): study design and first results","volume":"10","author":"Slot","year":"2018","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106331_bib42","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13195-017-0314-2","article-title":"Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer\u2019s disease (DELCODE)","volume":"10","author":"Jessen","year":"2018","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106331_bib43","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.50921","article-title":"Analysis of psychological symptoms following disclosure of amyloid-positron emission tomography imaging results to adults with subjective cognitive decline","volume":"6","author":"Caprioglio","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ebiom.2026.106331_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1533317520904551","article-title":"Disclosure of amyloid status for risk of alzheimer disease to cognitively normal research participants With subjective cognitive decline: a longitudinal study","volume":"35","author":"Wake","year":"2020","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"10.1016\/j.ebiom.2026.106331_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ebiom.2022.103836","article-title":"Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer\u2019s disease","volume":"76","author":"Ashton","year":"2022","journal-title":"EBioMedicine"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106331_bib46","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1007\/s00415-023-12148-5","article-title":"Head-to-head study of diagnostic accuracy of plasma and cerebrospinal fluid p-tau217 versus p-tau181 and p-tau231 in a memory clinic cohort","volume":"271","author":"Mendes","year":"2024","journal-title":"J Neurol"},{"key":"10.1016\/j.ebiom.2026.106331_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ebiom.2022.103936","article-title":"CSF p-tau231: a biomarker for early preclinical Alzheimer?","volume":"77","author":"Su\u00e1rez-Calvet","year":"2022","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106331_bib48","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13195-023-01201-0","article-title":"Clinical performance and head-to-head comparison of CSF p-tau235 with p-tau181, p-tau217 and p-tau231 in two memory clinic cohorts","volume":"15","author":"Lantero-Rodriguez","year":"2023","journal-title":"Alzheimers Res Ther"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106331_bib49","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3390\/cells13040331","article-title":"The relationship between p-tau217, p-tau231, and p-tau205 in the human brain is affected by the cellular environment and alzheimer\u2019s disease pathology","volume":"13","author":"Wennstr\u00f6m","year":"2024","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106331_bib50","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s00401-023-02659-w","article-title":"CSF p-tau205: a biomarker of tau pathology in Alzheimer\u2019s disease","volume":"147","author":"Lantero-Rodriguez","year":"2024","journal-title":"Acta Neuropathol"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106331_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15252\/emmm.202115098","article-title":"P-tau235: a novel biomarker for staging preclinical Alzheimer\u2019s disease","volume":"13","author":"Lantero-Rodriguez","year":"2021","journal-title":"EMBO Mol Med"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106331_bib52","doi-asserted-by":"crossref","first-page":"5343","DOI":"10.1002\/alz.13119","article-title":"Plasma and CSF concentrations of N-terminal tau fragments associate with in vivo neurofibrillary tangle burden","volume":"19","author":"Lantero-Rodriguez","year":"2023","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106331_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-024-61655-6","article-title":"Future perspective and clinical applicability of the combined use of plasma phosphorylated tau 181 and neurofilament light chain in subjective cognitive decline and mild cognitive impairment","volume":"14","author":"Giacomucci","year":"2024","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106331_bib54","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2967\/jnumed.122.264279","article-title":"A head-to-head comparison between plasma pTau181 and Tau PET along the alzheimer\u2019s disease continuum","volume":"64","author":"Coomans","year":"2023","journal-title":"J Nuclear Med"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106331_bib55","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/jamaneurol.2023.5319","article-title":"Diagnostic accuracy of a plasma phosphorylated Tau 217 immunoassay for alzheimer disease pathology","volume":"81","author":"Ashton","year":"2024","journal-title":"JAMA Neurol"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106331_bib56","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/jama.2020.12134","article-title":"Discriminative accuracy of plasma Phospho-tau217 for alzheimer disease vs other neurodegenerative disorders","volume":"324","author":"Palmqvist","year":"2020","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106331_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/braincomms\/fcad057","article-title":"Plasma phosphorylated tau 217 in preclinical Alzheimer\u2019s disease","volume":"5","author":"Jonaitis","year":"2023","journal-title":"Brain Commun"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106331_bib58","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1136\/jnnp-2024-333467","article-title":"Clinical value of plasma ALZpath pTau217 immunoassay for assessing mild cognitive impairment","volume":"95","author":"Lehmann","year":"2024","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106331_bib59","doi-asserted-by":"crossref","first-page":"5617","DOI":"10.1002\/alz.14073","article-title":"Plasma pTau217 predicts continuous brain amyloid levels in preclinical and early Alzheimer\u2019s disease","volume":"20","author":"Devanarayan","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106331_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/braincomms\/fcae162","article-title":"Plasma pTau181 and pTau217 predict asymptomatic amyloid accumulation equally well as amyloid PET","volume":"6","author":"De Meyer","year":"2024","journal-title":"Brain Commun"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106331_bib61","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1001\/jamaneurol.2021.3671","article-title":"Differences between plasma and cerebrospinal fluid glial fibrillary acidic protein levels across the alzheimer disease continuum","volume":"78","author":"Benedet","year":"2021","journal-title":"JAMA Neurol"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106331_bib62","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1002\/alz.12806","article-title":"Differences between blood and cerebrospinal fluid glial fibrillary acidic protein levels: the effect of sample stability","volume":"18","author":"Simr\u00e9n","year":"2022","journal-title":"Alzheimers Dement"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106331_bib63","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup","volume":"20","author":"Jack","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106331_bib64","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1001\/jamaneurol.2024.3770","article-title":"Alzheimer disease as a clinical-biological Construct-An international Working Group recommendation","volume":"81","author":"Dubois","year":"2024","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ebiom.2026.106331_bib65","article-title":"Dementia prevention in memory clinics: recommendations from the European task force for brain health services","volume":"26","author":"Frisoni","year":"2023","journal-title":"Lancet Reg Health Eur"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426002148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426002148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T08:10:13Z","timestamp":1783498213000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396426002148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":65,"alternative-id":["S2352396426002148"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106331","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detecting amyloid\u2013\u03b2 pathology in subjective cognitive decline using plasma and CSF biomarkers","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106331","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106331"}}